The technology used in the CasMed 740, to measure blood pressure, has passed in a clinical validation study, in a young population, according to a recognised standard protocol, as published in a peer-reviewed publication.
|Medaval||Recommended for children only||Validation in children|
|ESH (Europe)||Professional use for children||Published evidence|
Lang SM, Giuliano JS Jr, Carroll CL, Rosenkrantz TS, Eisenfeld L. Neonatal/infant validation study of the CAS model 740 noninvasive blood pressure monitor with the Orion/MaxIQ NIBP module. Blood Press Monit. 2014 Jun;19(3):180-2. doi: 10.1097/MBP.0000000000000036. PMID: 24618916.
81060-2:2009 - Pass Neonates and infants (n=29)